K-One Technology Berhad Zukünftiges Wachstum

Future Kriterienprüfungen 0/6

Wir verfügen derzeit nicht über ausreichende Analystenabdeckung, um Wachstum und Umsatz für K-One Technology Berhad zu prognostizieren.

Wichtige Informationen

n/a

Wachstumsrate der Gewinne

n/a

EPS-Wachstumsrate

Electronic Gewinnwachstum	23.6%
Wachstumsrate der Einnahmen	n/a
Zukünftige Eigenkapitalrendite	n/a
Analystenabdeckung	None
Zuletzt aktualisiert	n/a

Jüngste Aktualisierungen zum künftigen Wachstum

Keine Aktualisierungen

Recent updates

K-One Technology Berhad (KLSE:K1) Could Be Struggling To Allocate Capital

Sep 11

K-One Technology Berhad's (KLSE:K1) Popularity With Investors Under Threat As Stock Sinks 26%

Sep 11

Optimistic Investors Push K-One Technology Berhad (KLSE:K1) Shares Up 75% But Growth Is Lacking

Jul 12

K-One Technology Berhad's (KLSE:K1) 28% Share Price Surge Not Quite Adding Up

May 27

A Look At The Intrinsic Value Of K-One Technology Berhad (KLSE:K1)

Nov 03

We Think K-One Technology Berhad (KLSE:K1) Can Easily Afford To Drive Business Growth

May 09

We're Not Very Worried About K-One Technology Berhad's (KLSE:K1) Cash Burn Rate

Oct 26

Here's Why We're Not Too Worried About K-One Technology Berhad's (KLSE:K1) Cash Burn Situation

Jun 13

Key Things To Understand About K-One Technology Berhad's (KLSE:K1) CEO Pay Cheque

Nov 30

In diesem Abschnitt stellen wir normalerweise Umsatz- und Gewinnwachstumsprognosen vor, die auf den Konsensschätzungen professioneller Analysten basieren, um den Anlegern zu helfen, die Fähigkeit des Unternehmens zur Gewinnerzielung zu verstehen. Da K-One Technology Berhad jedoch nicht genügend Daten aus der Vergangenheit zur Verfügung gestellt hat und keine Analystenprognose vorliegt, können die zukünftigen Erträge nicht zuverlässig durch Extrapolation von Vergangenheitsdaten oder anhand von Analystenprognosen berechnet werden.

Dies ist eine recht seltene Situation, da 97 % der von SimplyWall St erfassten Unternehmen über Finanzdaten aus der Vergangenheit verfügen.

Gewinn- und Umsatzwachstumsprognosen

KLSE:K1 - Zukünftige Analystenschätzungen und Finanzdaten der Vergangenheit (MYR Millions)
Datum	Umsatz	Gewinne	Freier Cashflow	Bargeld aus operativen Tätigkeiten	Durchschn. Anz. Analysten
6/30/2024	173	4	0	6	N/A
3/31/2024	171	3	6	13	N/A
12/31/2023	167	0	10	16	N/A
9/30/2023	173	-2	15	18	N/A
6/30/2023	176	2	6	10	N/A
3/31/2023	168	-1	0	4	N/A
12/31/2022	165	0	-4	-1	N/A
9/30/2022	154	-3	-14	-11	N/A
6/30/2022	133	-7	-12	-10	N/A
3/31/2022	133	-3	-11	-9	N/A
12/31/2021	126	-3	-10	-9	N/A
9/30/2021	121	-6	-5	-1	N/A
6/30/2021	121	-3	-1	4	N/A
3/31/2021	105	-8	-4	0	N/A
12/31/2020	91	-9	0	5	N/A
9/30/2020	87	-1	2	5	N/A
6/30/2020	90	0	0	2	N/A
3/31/2020	96	4	5	8	N/A
12/31/2019	97	6	1	7	N/A
9/30/2019	89	7	-2	3	N/A
6/30/2019	82	8	-1	5	N/A
3/31/2019	73	7	-3	1	N/A
12/31/2018	74	6	-2	0	N/A
9/30/2018	74	1	-3	-2	N/A
6/30/2018	74	0	-5	-4	N/A
3/31/2018	77	-1	N/A	-6	N/A
12/31/2017	78	-10	N/A	2	N/A
9/30/2017	81	-14	N/A	9	N/A
6/30/2017	80	-17	N/A	8	N/A
3/31/2017	80	-17	N/A	5	N/A
12/31/2016	82	-9	N/A	2	N/A
9/30/2016	95	1	N/A	3	N/A
6/30/2016	117	8	N/A	6	N/A
3/31/2016	136	9	N/A	11	N/A
12/31/2015	146	11	N/A	7	N/A
9/30/2015	166	11	N/A	15	N/A
6/30/2015	174	9	N/A	20	N/A
3/31/2015	173	9	N/A	24	N/A
12/31/2014	186	12	N/A	30	N/A
9/30/2014	184	10	N/A	21	N/A
6/30/2014	182	9	N/A	16	N/A
3/31/2014	181	10	N/A	18	N/A
12/31/2013	171	1	N/A	15	N/A

Analystenprognosen zum zukünftigen Wachstum

Einkommen vs. Sparrate: Unzureichende Daten, um festzustellen, ob das prognostizierte Gewinnwachstum von K1 über der Sparquote liegt (3.6%).

Ertrag vs. Markt: Unzureichende Daten, um festzustellen, ob die Gewinne von K1 schneller wachsen werden als der Markt MY

Hohe Wachstumserträge: Die Daten reichen nicht aus, um festzustellen, ob die Einnahmen von K1 in den nächsten 3 Jahren erheblich steigen werden.

Einnahmen vs. Markt: Die Daten reichen nicht aus, um festzustellen, ob die Einnahmen von K1 schneller wachsen werden als der Markt von MY.

Hohe Wachstumseinnahmen: Es liegen keine ausreichenden Daten vor, um festzustellen, ob die Einnahmen von K1 schneller wachsen werden als 20% pro Jahr.

Wachstumsprognosen für den Gewinn je Aktie

Künftige Eigenkapitalrendite

Künftige Eigenkapitalrendite: Unzureichende Daten, um festzustellen, ob die Eigenkapitalrendite von K1 in 3 Jahren voraussichtlich hoch sein wird

K-One Technology Berhad Zukünftiges Wachstum

Future Kriterienprüfungen 0/6

Wichtige Informationen

Jüngste Aktualisierungen zum künftigen Wachstum

Recent updates

K-One Technology Berhad (KLSE:K1) Could Be Struggling To Allocate Capital

K-One Technology Berhad's (KLSE:K1) Popularity With Investors Under Threat As Stock Sinks 26%

Second quarter 2024 earnings released: EPS: RM0.001 (vs RM0 in 2Q 2023)

Optimistic Investors Push K-One Technology Berhad (KLSE:K1) Shares Up 75% But Growth Is Lacking

K-One Technology Berhad Announces Resignation of Wong Youn Kim as Company Secretary

First quarter 2024 earnings released: EPS: RM0.002 (vs RM0.001 loss in 1Q 2023)

K-One Technology Berhad's (KLSE:K1) 28% Share Price Surge Not Quite Adding Up

K-One Technology Berhad, Annual General Meeting, Jun 19, 2024

New major risk - Revenue and earnings growth

K-One Technology Berhad Appoints Wong Mee Kiat as Joint Secretary

Full year 2023 earnings released: EPS: RM0 (vs RM0 in FY 2022)

Third quarter 2023 earnings released: RM0.002 loss per share (vs RM0.002 profit in 3Q 2022)

New minor risk - Share price stability

A Look At The Intrinsic Value Of K-One Technology Berhad (KLSE:K1)

Now 20% undervalued after recent price drop

K-One Meditech Sdn Bhd Receives Approval from the Medical Device Authority Under the Ministry of Health, Malaysia for Registration of Diversey's Oxivir Excel Disinfectant Wipes Used for Cleaning Surfaces and Equipment

Second quarter 2023 earnings released: EPS: RM0 (vs RM0.003 loss in 2Q 2022)

First quarter 2023 earnings released: EPS: RM0 (vs RM0.001 in 1Q 2022)

K-One Technology Berhad Announces Cessation of Office of Loi Kim Fah as Independent and Non Executive Chairman of Risk Committee

K-One Technology Berhad Announces Cessation of GOH CHONG CHUANG as Independent and Non Executive Chairman of Nomination Committee

We Think K-One Technology Berhad (KLSE:K1) Can Easily Afford To Drive Business Growth

Full year 2022 earnings released: EPS: RM0 (vs RM0.003 loss in FY 2021)

Third quarter 2022 earnings released: EPS: RM0.002 (vs RM0.003 loss in 3Q 2021)

Insufficient new directors

We're Not Very Worried About K-One Technology Berhad's (KLSE:K1) Cash Burn Rate

Medical Device Authority of Malaysia Grants Approval to K-One Meditech Sdn Bhd to Distribute Silicone Adhesive Tape Primarily Used for Wound Care Dressing

K-One Technology Berhad Provides Impairment of Plant and Equipment for the Second Quarter Ended June 30, 2022

Second quarter 2022 earnings released: RM0.003 loss per share (vs RM0.002 profit in 2Q 2021)

Medical Device Authority (MDA) of Malaysia Approves COVID-19 Antigen Self-Test Kit (Saliva) for Distribution by K-One MediTech Sdn Bhd

K-One Technology Berhad Announces the Appointment of Independent and Non Executive Member of Audit Committee

Here's Why We're Not Too Worried About K-One Technology Berhad's (KLSE:K1) Cash Burn Situation

First quarter 2022 earnings released: EPS: RM0.001 (vs RM0.001 in 1Q 2021)

Insufficient new directors

Full year 2021 earnings: Revenues and EPS in line with analyst expectations

We're Not Worried About K-One Technology Berhad's (KLSE:K1) Cash Burn

Third quarter 2021 earnings: Revenues and EPS in line with analyst expectations

We're Hopeful That K-One Technology Berhad (KLSE:K1) Will Use Its Cash Wisely

Second quarter 2021 earnings released: EPS RM0.002 (vs RM0.004 loss in 2Q 2020)

K-One Technology Berhad Announces Approval of Low Dead Volume Syringes Suitable for Covid-19 Vaccination by Medical Device Authority, Malaysia

Full year 2020 earnings released: RM0.012 loss per share (vs RM0.008 profit in FY 2019)

New 90-day low: RM0.30

Full year 2020 earnings released: RM0.012 loss per share (vs RM0.008 profit in FY 2019)

New 90-day low: RM0.33

Is K-One Technology Berhad's (KLSE:K1) Share Price Gain Of 115% Well Earned?

New 90-day low: RM0.33

Key Things To Understand About K-One Technology Berhad's (KLSE:K1) CEO Pay Cheque

Third quarter 2020 earnings released: EPS RM0.001

G-AsiaPacific (S) Pte Ltd Enters into an Agreement to Provide Amazon Web Services Cloud Services

New 90-day low: RM0.34

K-One Meditech Sdn Bhd Signs License Agreement with Star Syringe, Uk to Manufacture Syringe Safety Needle Cap in Malaysia & Distribute Worldwide

New 90-day low: RM0.35

New 90-day low - RM0.37

First half earnings released

New 90-day high - RM0.59

Gewinn- und Umsatzwachstumsprognosen

Analystenprognosen zum zukünftigen Wachstum

Wachstumsprognosen für den Gewinn je Aktie

Künftige Eigenkapitalrendite

Wachstumsunternehmen entdecken